Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7971-7980 of 11994

Page
per page
  1. AKT/mTOR Set I
    A9904 AKT/mTOR Set I
    Summary: For inhibiting AKT/mTOR
  2. TG003
    B1431 TG003
    Target: Cdc2-like kinase (Clk)
    Summary: Cdc2-like kinase (Clk) inhibitor
      insoluble in H2O; ≥12.45 mg/mL
  3. OSI-027
    B1637 OSI-027
    Summary: MTORC1/ mTORC2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥32.5 mg/mL
  4. SB590885
    B1406 SB590885
     1 Citation
    Summary: Potent B-Raf inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.54 mg/mL
  5. Cabozantinib malate (XL184)
    B1401 Cabozantinib malate (XL184)
    Summary: MET andVEGF receptor2 inhibitor
      ≥31.8 mg/mL
  6. β-Glycerophosphate disodium salt hydrate
    A4724 β-Glycerophosphate disodium salt hydrate
      Soluble in DMSO
  7. Afatinib
    A4746 Afatinib
     2 Citation
    Summary: A covalent inhibitor targeting members of the ErbB family
      ≥49.3 mg/mL
  8. Mitraphylline
    A9072 Mitraphylline
    Summary: Major pentacyclic oxindole alkaloid found in Uncaria tomentosa, inhibits lipopolysaccharide-induced activation of primary human neutrophils.
      ≥9.13 mg/mL
  9. Cloxiquine
    C6883 Cloxiquine
      ≥27.3 mg/mL
  10. Myclobutanil
    C6981 Myclobutanil
      ≥56.3 mg/mL

Items 7971-7980 of 11994

Page
per page